ARN-3236   Click here for help

GtoPdb Ligand ID: 9581

Synonyms: example 86 [WO2014093383]
Compound class: Synthetic organic
Comment: ARN-3236 is an orally active, ATP-competitive inhibitor of salt-inducible kinases (SIKs) [3]. It is one of the chemical structures claimed in patent WO2014093383, in which it is referred to as Example 86 or compound 114 [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 75.38
Molecular weight 336.09
XLogP 4.63
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1cc(OC)ccc1c1c[nH]c2c1c(ccn2)c1cscc1
Isomeric SMILES COc1cc(OC)ccc1c1c[nH]c2c1c(ccn2)c1cscc1
InChI InChI=1S/C19H16N2O2S/c1-22-13-3-4-15(17(9-13)23-2)16-10-21-19-18(16)14(5-7-20-19)12-6-8-24-11-12/h3-11H,1-2H3,(H,20,21)
InChI Key WEHOIIGXTMKVRG-UHFFFAOYSA-N
References
1. Lombardi MS, Gilliéron C, Dietrich D, Gabay C. (2016)
SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype.
J Leukoc Biol, 99 (5): 711-21. [PMID:26590148]
2. Vankayalapati H, Yerramreddy V, Ganipisetty VB, Talluri S, Appalaneni RP. (2014)
Substituted 1h-pyrrolo [2,3-b] pyridine and 1h-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (sik2) inhibitors.
Patent number: WO2014093383. Assignee: Arrien Pharmaceuticals Llc. Priority date: 14/12/2012. Publication date: 19/06/2014.
3. Zhou J, Alfraidi A, Zhang S, Santiago-O'Farrill JM, Yerramreddy Reddy VK, Alsaadi A, Ahmed AA, Yang H, Liu J, Mao W et al.. (2017)
A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel.
Clin Cancer Res, 23 (8): 1945-1954. [PMID:27678456]